Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

  • Kentaro Minagawa,
  • Muhammad O. Jamil,
  • Mustafa AL-Obaidi,
  • Larisa Pereboeva,
  • Donna Salzman,
  • Harry P. Erba,
  • Lawrence S. Lamb,
  • Ravi Bhatia,
  • Shin Mineishi,
  • Antonio Di Stasi

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

  • Kentaro Minagawa, 
  • Muhammad O. Jamil, 
  • Mustafa AL-Obaidi, 
  • Larisa Pereboeva, 
  • Donna Salzman, 
  • Harry P. Erba, 
  • Lawrence S. Lamb, 
  • Ravi Bhatia, 
  • Shin Mineishi, 
  • Antonio Di Stasi
PLOS
x

The following information is missing from the Funding section: A.D. was supported by an American Cancer Society (ACS) New faculty Career Development Grant, and by a “Walter B. Frommeyer Jr. Fellowship in investigative medicine."

Reference

  1. 1. Minagawa K, Jamil MO, AL-Obaidi M, Pereboeva L, Salzman D, Erba HP, et al. (2016) In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS ONE 11(12): e0166891. pmid:27907031